Theodoros Kelesidis
Websites:
Publications:
Abedi F, Sadeghi M, Omidkhoda N, Kelesidis T, Ramezani J, Samadi S, Mohammadpour AH. HDL-cholesterol concentration and its association with coronary artery calcification: a systematic review and meta-analysis. Lipids Health Dis. 2023 May 08; 22(1):60. view on PubMed
Kelesidis T. Sleep and mood disturbances in people with HIV remain largely understudied. AIDS. 2023 May 01; 37(6):993-994. view on PubMed
Song S, Satta S, Sharma MB, Hugo C, Kossyvakis A, Sen Roy S, Kelesidis T. Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection. J Infect Dis. 2023 Mar 24. view on PubMed
Kelesidis T, Sharma M, Satta S, Tran E, Gupta R, Araujo JA, Middlekauff HR. Ectodomain shedding of proteins important for SARS-CoV-2 pathogenesis in plasma of tobacco cigarette smokers compared to electronic cigarette vapers: a cross-sectional study. J Mol Med (Berl). 2023 03; 101(3):327-335. view on PubMed
Ritou E, Satta S, Petcherski A, Daskou M, Sharma M, Vasilopoulos H, Murakami E, Shirihai OS, Kelesidis T. Blood immune cells from people with HIV on antiviral regimens that contain tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) have differential metabolic signatures. Metabolism. 2023 04; 141:155395. view on PubMed
Gain C, Song S, Angtuaco T, Satta S, Kelesidis T. The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front Microbiol. 2022; 13:1111930. view on PubMed
Jaehn P, Sasko B, Holmberg C, Hoffmann S, Spallek J, Kelesidis T, Rapp M, Westhoff TH, Ritter O, Pagonas N. Levels of high-density lipoprotein lipid peroxidation according to spatial socioeconomic deprivation and rurality among patients with coronary artery disease. Eur J Prev Cardiol. 2022 Nov 08; 29(15):e343-e346. view on PubMed
Satta S, Hugo C, Sharma M, Rezek V, Kossyvakis A, Roy SS, Kitchen S, Kelesidis T. Mitoquinone mesylate attenuates brain inflammation in humanized mouse model of chronic HIV infection. AIDS. 2022 09 01; 36(11):1609-1611. view on PubMed
Kelesidis T, Mantzoros CS. Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection. Metabolism. 2022 09; 134:155267. view on PubMed
Koethe JR, Moser C, Brown TT, Stein JH, Kelesidis T, Dube M, Currier J, McComsey GA. Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s. Clin Infect Dis. 2022 03 09; 74(5):857-864. view on PubMed
Petcherski A, Sharma M, Daskou M, Satta S, Vasilopoulos H, Hugo C, Ritou E, Dillon BJ, Fung E, Garcia G, Scafoglio C, Purkayastha A, Gomperts BN, Fishbein GA, Arumugaswami V, Liesa M, Shirihai OS, Kelesidis T. Mitoquinone mesylate targets SARS-CoV-2 and associated lung inflammation through host pathways. bioRxiv. 2022 Mar 09. view on PubMed
Kelesidis T, Zhang Y, Tran E, Sosa G, Middlekauff HR. Instigators of COVID-19 in Immune Cells Are Increased in Tobacco Cigarette Smokers and Electronic Cigarette Vapers Compared With Nonsmokers. Nicotine Tob Res. 2022 02 14; 24(3):413-415. view on PubMed
Flaherty SM, Wood EK, Ryff CD, Love GD, Kelesidis T, Berkowitz L, Echeverría G, Rivera K, Rigotti A, Coe CL. Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes. Lipids Health Dis. 2022 Feb 06; 21(1):18. view on PubMed
Daskou M, Mu W, Sharma M, Vasilopoulos H, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T. ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV. PLoS Pathog. 2022 01; 18(1):e1010160. view on PubMed
Kelesidis T, Madhav S, Petcherski A, Cristelle H, O'Connor E, Hultgren NW, Ritou E, Williams DS, Shirihai OS, Reddy ST. The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells. Virulence. 2021 12; 12(1):2214-2227. view on PubMed
Kelesidis T, Tran E, Nguyen R, Zhang Y, Sosa G, Middlekauff HR. Association of 1 Vaping Session With Cellular Oxidative Stress in Otherwise Healthy Young People With No History of Smoking or Vaping: A Randomized Clinical Crossover Trial. JAMA Pediatr. 2021 11 01; 175(11):1174-1176. view on PubMed
Sarkar S, Haberlen S, Post WS, Kelesidis T, Wiley D, Kingsley L, Kim EY, Palella FJ, Witt MD, Budoff MJ, Rodriguez A, Brown TT. Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study. AIDS Res Hum Retroviruses. 2021 11; 37(11):842-845. view on PubMed
Sarkar S, Haberlen S, Post WS, Kelesidis T, Wiley D, Kingsley L, Kim EY, Palella FJ, Witt MD, Budoff MJ, Rodriguez A, Brown TT. Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study. AIDS Res Hum Retroviruses. 2021 Sep 20. view on PubMed
Daskou M, Sharma M, Mu W, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Papesh J, Meriwether D, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T. ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV. Metabolism. 2021 11; 124:154888. view on PubMed
El Kamari V, Rodriguez K, Moser C, Currier JS, Kelesidis T, Stein JH, Brown TT, Howell SK, Beisswenger PJ, McComsey GA. Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2021 Oct; 8(10):ofab423. view on PubMed
Gupta R, Lin Y, Luna K, Logue A, Yoon AJ, Haptonstall KP, Moheimani R, Choroomi Y, Nguyen K, Tran E, Zhu Y, Faull KF, Kelesidis T, Gornbein J, Middlekauff HR, Araujo JA. Electronic and Tobacco Cigarettes Alter Polyunsaturated Fatty Acids and Oxidative Biomarkers. Circ Res. 2021 08 20; 129(5):514-526. view on PubMed
Kelesidis T, Zhang Y, Tran E, Sosa G, Middlekauff HR. Increased Expression of Proatherogenic Proteins in Immune Cell Subtypes in Tobacco Cigarette Smokers But Not in Electronic Cigarette Vapers. Can J Cardiol. 2021 08; 37(8):1175-1180. view on PubMed
Mu W, Sharma M, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Papesh J, Meriwether D, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T. Apolipoprotein A-I mimetics attenuate macrophage activation in chronic treated HIV. AIDS. 2021 03 15; 35(4):543-553. view on PubMed
Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S. Update in Viral Infections in the Intensive Care Unit. Front Med (Lausanne). 2021; 8:575580. view on PubMed
Kelesidis T, Zhang Y, Tran E, Sosa G, Middlekauff HR. Expression of Key Inflammatory Proteins Is Increased in Immune Cells From Tobacco Cigarette Smokers But Not Electronic Cigarette Vapers: Implications for Atherosclerosis. J Am Heart Assoc. 2021 01 05; 10(1):e019324. view on PubMed
Kelesidis T, Tran E, Arastoo S, Lakhani K, Heymans R, Gornbein J, Middlekauff HR. Elevated Cellular Oxidative Stress in Circulating Immune Cells in Otherwise Healthy Young People Who Use Electronic Cigarettes in a Cross-Sectional Single-Center Study: Implications for Future Cardiovascular Risk. J Am Heart Assoc. 2020 09 15; 9(18):e016983. view on PubMed
Dixit NM, Truong KP, Rabadia SV, Li D, Srivastava PK, Mosaferi T, Calfon Press MA, Donangelo I, Kelesidis T. Sudden Cardiac Arrest in a Patient With Myxedema Coma and COVID-19. J Endocr Soc. 2020 Oct 01; 4(10):bvaa130. view on PubMed
Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2020 06 11; 221(12):2083-2084. view on PubMed
Adamson PC, Judson SD, Klausner JD, Kelesidis T. Neisseria gonorrhoeae as a Rare Cause of Preseptal Cellulitis. Sex Transm Dis. 2019 12; 46(12):813-815. view on PubMed
Sarkar S, Haberlen S, Whelton S, E Schneider E, Kingsley L, Palella F, Witt MD, Kelesidis T, Rodriguez A, Post WS, Brown TT. Greater IL-6, D-dimer, and ICAM-1 Levels Are Associated With Lower Small HDL Particle Concentration in the Multicenter AIDS Cohort Study. Open Forum Infect Dis. 2019 Dec; 6(12):ofz474. view on PubMed
Mu W, Homann S, Hofmann C, Gorin A, Huynh D, Yang OO, Kelesidis T. A Flow Cytometric Method to Determine Transfection Efficiency. Bio Protoc. 2019 May 20; 9(10). view on PubMed
Pagonas N, Vlatsas S, Bauer F, Seibert FS, Sasko B, Buschmann I, Ritter O, Kelesidis T, Westhoff TH. The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension. Eur J Prev Cardiol. 2019 08; 26(12):1301-1309. view on PubMed
Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS. Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial. Diabetes Obes Metab. 2019 06; 21(6):1487-1492. view on PubMed
Samadi S, Mehramiz M, Kelesidis T, Mobarhan MG, Sahebkar AH, Esmaily H, Moohebati M, Farjami Z, Ferns GA, Mohammadpour AH, Avan A. High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort. J Cell Physiol. 2019 Feb 19. view on PubMed
Samadi S, Abolbashari S, Meshkat Z, Mohammadpour AH, Kelesidis T, Gholoobi A, Mehramiz M, Tabadkani M, Sadabadi F, Dalirfardouei R, Ferns GA, Ghayour-Mobarhan M, Avan A. Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations. Biofactors. 2019 May; 45(3):374-380. view on PubMed
Christodoulides A, Gupta N, Yacoubian V, Maithel N, Parker J, Kelesidis T. The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation. Front Microbiol. 2018; 9:1682. view on PubMed
Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):362-366. view on PubMed
Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AM. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332. Medicine (Baltimore). 2018 Jun; 97(22):e10955. view on PubMed
Seang S, Kelesidis T, Huynh D, Park S, Moe AA, Currier JS, Lake JE. Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men. AIDS Res Hum Retroviruses. 2018 01; 34(1):39-45. view on PubMed
Angelovich TA, Hearps AC, Oda MN, Borja MS, Huynh D, Homann S, Jaworowski A, Kelesidis T. Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro. AIDS. 2017 11 13; 31(17):2331-2336. view on PubMed
Angelovich TA, Hearps AC, Maisa A, Kelesidis T, Jaworowski A. Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions. J Vis Exp. 2017 10 17; (128). view on PubMed
Sen Roy S, Nguyen HCX, Angelovich TA, Hearps AC, Huynh D, Jaworowski A, Kelesidis T. Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein. J Vis Exp. 2017 10 12; (128). view on PubMed
Homann S, Hofmann C, Gorin AM, Nguyen HCX, Huynh D, Hamid P, Maithel N, Yacoubian V, Mu W, Kossyvakis A, Sen Roy S, Yang OO, Kelesidis T. A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells. PLoS One. 2017; 12(9):e0182941. view on PubMed
Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS. Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):354-363. view on PubMed
Christodoulides A, Boyadjian A, Kelesidis T. Spirochetal Lipoproteins and Immune Evasion. Front Immunol. 2017; 8:364. view on PubMed
Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah H, Park SY, Nguyen MH, Razonable RR. Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1. Emerg Infect Dis. 2017 03; 23(3):510-512. view on PubMed
Kim JY, Kelesidis T, Yang OO. Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection. Transplant Direct. 2017 Mar; 3(3):e131. view on PubMed
Kelesidis T, Schmid I. Assessment of Telomere Length, Phenotype, and DNA Content. Curr Protoc Cytom. 2017 01 05; 79:7.26.1-7.26.23. view on PubMed
Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS. 2016 11 13; 30(17):2625-2633. view on PubMed
Davidson WS, Inge TH, Sexmith H, Heink A, Elder D, Hui DY, Melchior JT, Kelesidis T, Shah AS. Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function. Int J Obes (Lond). 2017 01; 41(1):83-89. view on PubMed
Kelesidis T, Tran TTT, Brown TT, Moser C, Ribaudo HJ, Dube MP, Yang OO, McComsey GA, Stein JH, Currier JS. Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s. Antivir Ther. 2017; 22(2):113-126. view on PubMed
Lake JE, Seang S, Kelesidis T, Currier JS, Yang OO. Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study. HIV Clin Trials. 2016 11; 17(6):225-232. view on PubMed
Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA. Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016 Sep; 3(3):ofw174. view on PubMed
Danoff A, Kendall MA, Currier JS, Kelesidis T, Schmidt AM, Aberg JA. Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332. Inflammation. 2016 Aug; 39(4):1354-62. view on PubMed
Kelesidis T, Moser C, Stein JH, Brown TT, Tran TT, Ribaudo HJ, Dube MP, Yang OO, Currier JS, McComsey GA. Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. J Infect Dis. 2016 09 01; 214(5):748-52. view on PubMed
McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT. Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s. Clin Infect Dis. 2016 Apr 01; 62(7):853-62. view on PubMed
Baghdadi J, Hemarajata P, Humphries R, Kelesidis T. First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianii. Case Rep Infect Dis. 2015; 2015:630816. view on PubMed
Kelesidis T, Braykov N, Uslan DZ, Morgan DJ, Gandra S, Johannsson B, Schweizer ML, Weisenberg SA, Young H, Cantey J, Perencevich E, Septimus E, Srinivasan A, Laxminarayan R. Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study. Infect Control Hosp Epidemiol. 2016 Jan; 37(1):70-9. view on PubMed
Kelesidis T, Papakonstantinou V, Detopoulou P, Fragopoulou E, Chini M, Lazanas MC, Antonopoulou S. The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection. AIDS Rev. 2015 Oct-Dec; 17(4):191-201. view on PubMed
Kelesidis T, Falagas ME. The safety of polymyxin antibiotics. Expert Opin Drug Saf. 2015; 14(11):1687-701. view on PubMed
Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH, Currier JS. Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study. HIV Clin Trials. 2015 Oct; 16(5):197-206. view on PubMed
Hindler JA, Wong-Beringer A, Charlton CL, Miller SA, Kelesidis T, Carvalho M, Sakoulas G, Nonejuie P, Pogliano J, Nizet V, Humphries R. In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci. Antimicrob Agents Chemother. 2015 Jul; 59(7):4279-88. view on PubMed
Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2015 Oct 15; 212(8):1241-9. view on PubMed
Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clin Infect Dis. 2015 Aug 15; 61(4):651-60. view on PubMed
Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015 Apr; 28(2):443-64. view on PubMed
Kelesidis T, Mastoris I, Metsini A, Tsiodras S. How to approach and treat viral infections in ICU patients. BMC Infect Dis. 2014 Nov 28; 14:321. view on PubMed
Braykov NP, Morgan DJ, Schweizer ML, Uslan DZ, Kelesidis T, Weisenberg SA, Johannsson B, Young H, Cantey J, Srinivasan A, Perencevich E, Septimus E, Laxminarayan R. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014 Dec; 14(12):1220-7. view on PubMed
Kelesidis T, Roberts CK, Huynh D, Martínez-Maza O, Currier JS, Reddy ST, Yang OO. A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS One. 2014; 9(11):e111716. view on PubMed
Yang OO, Kelesidis T, Cordova R, Khanlou H. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. AIDS Res Hum Retroviruses. 2014 Oct; 30(10):988-95. view on PubMed
Kelesidis T, Currier JS. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am. 2014 Sep; 43(3):665-84. view on PubMed
Kelesidis T, Currier JS, Yang OO, Brown TT. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. AIDS Rev. 2014 Jul-Sep; 16(3):123-33. view on PubMed
Kelesidis T. The Cross-Talk between Spirochetal Lipoproteins and Immunity. Front Immunol. 2014; 5:310. view on PubMed
Tewhey R, Gu B, Kelesidis T, Charlton C, Bobenchik A, Hindler J, Schork NJ, Humphries RM. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing. mBio. 2014 May 13; 5(3):e00894-14. view on PubMed
Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK. HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque. Antivir Ther. 2014; 19(8):805-811. view on PubMed
Kelesidis T. The Interplay between Daptomycin and the Immune System. Front Immunol. 2014; 5:52. view on PubMed
Kelesidis T. The zoonotic potential of daptomycin non-susceptible enterococci. Zoonoses Public Health. 2015 Feb; 62(1):1-6. view on PubMed
Giltner CL, Kelesidis T, Hindler JA, Bobenchik AM, Humphries RM. Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2014 Jan; 52(1):357-61. view on PubMed
Roberts CK, Katiraie M, Croymans DM, Yang OO, Kelesidis T. Untrained young men have dysfunctional HDL compared with strength-trained men irrespective of body weight status. J Appl Physiol (1985). 2013 Oct 01; 115(7):1043-9. view on PubMed
Kelesidis T, Humphries R, Chow ALP, Tsiodras S, Uslan DZ. Emergence of daptomycin-non-susceptible enterococci urinary tract isolates. J Med Microbiol. 2013 Jul; 62(Pt 7):1103-1105. view on PubMed
Kelesidis T, Chow AL. Proximity to animal or crop operations may be associated with de novo daptomycin-non-susceptible Enterococcus infection. Epidemiol Infect. 2014 Jan; 142(1):221-4. view on PubMed
Kelesidis T, Tewhey R, Humphries RM. Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome. J Antimicrob Chemother. 2013 Aug; 68(8):1926-8. view on PubMed
Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS. Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults. Lipids Health Dis. 2013 Mar 05; 12:23. view on PubMed
Kelesidis T, Kendall MA, Yang OO, Hodis H, Currier JS. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. AIDS Res Hum Retroviruses. 2013 Jun; 29(6):938-48. view on PubMed
Kelesidis T. Transport of daptomycin resistance genes between animals and humans as a possible mechanism for development of de novo daptomycin resistance in enterococci. Epidemiol Infect. 2013 Oct; 141(10):2185-6. view on PubMed
Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis. 2012 Nov 15; 206(10):1558-67. view on PubMed
Humphries RM, Kelesidis T, Tewhey R, Rose WE, Schork N, Nizet V, Sakoulas G. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2012 Nov; 56(11):6051-3. view on PubMed
Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother. 2013 Jan; 68(1):4-11. view on PubMed
Kelesidis T, Reddy ST, Huynh D, Meriwether D, Fogelman AM, Navab M, Yang OO. Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity. Lipids Health Dis. 2012 Jul 06; 11:87. view on PubMed
Kelesidis T, Tsiodras S. Extraparenchymal neurocysticercosis in the United States. Am J Med Sci. 2012 Jul; 344(1):79-82. view on PubMed
Kelesidis T, Humphries R, Terashita D, Eshaghian S, Territo MC, Said J, Lewinski M, Currier JS, Pegues D. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County. J Med Virol. 2012 May; 84(5):777-85. view on PubMed
Kelesidis T, Humphries R, Uslan DZ, Pegues D. De novo daptomycin-nonsusceptible enterococcal infections. Emerg Infect Dis. 2012 Apr; 18(4):674-6. view on PubMed
Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol. 2012 Mar; 5(2):111-25. view on PubMed
Tsiodras S, Drogari-Apiranthitou M, Pilichos K, Leventakos K, Kelesidis T, Buitrago MJ, Petrikkos G, Panayiotides I. An unusual cutaneous tumor: African histoplasmosis following mudbaths: case report and review. Am J Trop Med Hyg. 2012 Feb; 86(2):261-3. view on PubMed
Kelesidis T, Chow AL, Humphries R, Uslan DZ, Pegues D. Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections. Antimicrob Agents Chemother. 2012 Apr; 56(4):2150-2. view on PubMed
Kelesidis T. Gastrointestinal symptoms among ambulatory HIV patients: appropriate symptom management requires improved symptom recognition. Ann Gastroenterol. 2012; 25(3):186-187. view on PubMed
Kelesidis T. Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections. J Antimicrob Chemother. 2012 Feb; 67(2):515-6. view on PubMed
Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO. A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011 Dec; 52(12):2341-2351. view on PubMed
Kelesidis T, Theodoros K, Tsiodras S, Sotirios T. Successful treatment of azole-resistant Candida spondylodiscitis with high-dose caspofungin monotherapy. Rheumatol Int. 2012 Sep; 32(9):2957-8. view on PubMed
Kelesidis T, Humphries R, Ward K, Lewinski MA, Yang OO. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis. 2011 Nov; 71(3):286-90. view on PubMed
Kelesidis T, Tsiodras S. Extraparenchymal neurocysticercosis in the United States: a case report. J Med Case Rep. 2011 Aug 09; 5:359. view on PubMed
Kelesidis T, Kelesidis I, Lewinski MA, Humphries R. Establishing diagnosis of Haemophilus parainfluenzae as etiology of culture-negative endocarditis using DNA sequence analysis on tissue specimen. Am J Med. 2011 Jul; 124(7):e9-e10. view on PubMed
Kelesidis T, Aish L, Steller MA, Aish IS, Shen J, Foukas P, Panayiotides J, Petrikkos G, Karakitsos P, Tsiodras S. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection. Am J Clin Pathol. 2011 Jul; 136(1):119-27. view on PubMed
Kelesidis T, Thian N. Multiple intraventricular neurocysticercal cysts treated with endoscopy without antiparasitic therapy. Am J Trop Med Hyg. 2011 Jul; 85(1):1-2. view on PubMed
Kelesidis T, Landovitz RJ. Preexposure prophylaxis for HIV prevention. Curr HIV/AIDS Rep. 2011 Jun; 8(2):94-103. view on PubMed
Kelesidis T, Tsiodras S. Hypopituitarism caused by neurocysticercosis. Am J Med Sci. 2011 May; 341(5):414-6. view on PubMed
Kelesidis T. Bloodstream infection with Anaerobiospirillum succiniciproducens: a potentially lethal infection. South Med J. 2011 Mar; 104(3):205-14. view on PubMed
Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M. HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis. 2011 Feb 23; 10:35. view on PubMed
Kelesidis T, Raphael J, Blanchard E. Correction:Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report. J Med Case Rep. 2011 Feb 22; 5:73. view on PubMed
Kelesidis T, Humphries R, Uslan DZ, Pegues DA. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis. 2011 Jan 15; 52(2):228-34. view on PubMed
Kelesidis T, Tsiodras S. Clostridium sphenoides bloodstream infection in man. Emerg Infect Dis. 2011 Jan; 17(1):156-8. view on PubMed
Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis. 2011 Jan; 15(1):e2-16. view on PubMed
Humphries RM, Kelesidis T, Dien Bard J, Ward KW, Bhattacharya D, Lewinski MA. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol. 2010 Nov; 59(Pt 11):1383-1386. view on PubMed
Kelesidis T, Raphael J, Blanchard E, Parameswaran R. Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report. J Med Case Rep. 2010 07 29; 4:231. view on PubMed
Kelesidis T, Tsiodras S. Staphylococcus intermedius is not only a zoonotic pathogen, but may also cause skin abscesses in humans after exposure to saliva. Int J Infect Dis. 2010 Oct; 14(10):e838-41. view on PubMed
Kelesidis T, Osman S, Dinerman H. An unusual foreign body as cause of chronic sinusitis: a case report. J Med Case Rep. 2010 May 26; 4:157. view on PubMed
Mantzoros CS, Sweeney L, Williams CJ, Oken E, Kelesidis T, Rifas-Shiman SL, Gillman MW. Maternal diet and cord blood leptin and adiponectin concentrations at birth. Clin Nutr. 2010 Oct; 29(5):622-6. view on PubMed
Kelesidis T, Dien Bard J, Humphries R, Ward K, Lewinski MA, Uslan DZ. First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin. J Clin Microbiol. 2010 May; 48(5):1970-3. view on PubMed
Kelesidis T, Fleisher J, Tsiodras S. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review. Clin Ther. 2010 Mar; 32(3):515-26. view on PubMed
Yang OO, Kelesidis T. Interleukin-2-unresponsive immune defects in good syndrome: Letter to the Editor. Clin Immunol. 2010 Jun; 135(3):496-8. view on PubMed
Kelesidis T, Salhotra A, Fleisher J, Uslan DZ. Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections? J Infect. 2010 May; 60(5):386-96. view on PubMed
Kelesidis T, Yang O. Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. Clin Immunol. 2010 Jun; 135(3):347-63. view on PubMed
Kelesidis T, Maysky M, Kelesidis I. Giant right atrium with severe pulmonary hypertension. CMAJ. 2010 Feb 23; 182(3):E147. view on PubMed
Kelesidis T, Canseco E. Giant inguinoscrotal hernia as a cause of hydronephrosis. Am J Med Sci. 2010 Feb; 339(2):174. view on PubMed
Kelesidis T, Canseco E. Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect. Am J Med. 2010 Feb; 123(2):e5-6. view on PubMed
Kelesidis T, Tsiodras S. Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option? Scand J Infect Dis. 2010; 42(1):12-21. view on PubMed
Kelesidis T, Osman S, Trayner E, Worthington M, Celli B. Tracheobronchitis caused by methicillin-resistant Staphylococcus aureus as a cause of chronic wheezing in a non-ventilated adult patient with tracheobronchomalacia. Respiration. 2010; 80(2):148-56. view on PubMed
Kelesidis T, Kelesidis I. Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin. Clin Ther. 2009 Dec; 31(12):2894-9. view on PubMed
Kelesidis T, Osman S, Tsiodras S. Emphysematous cystitis in the absence of known risk factors: an unusual clinical entity. South Med J. 2009 Sep; 102(9):942-6. view on PubMed
Kelesidis T, Tarbox A, Lopez M, Aish L. Perineurioma of esophagus: a first case report. Am J Med Sci. 2009 Sep; 338(3):230-2. view on PubMed
Kelesidis T, Tsiodras S. Postirradiation Klebsiella pneumoniae-associated necrotizing fasciitis in the western hemisphere: a rare but life-threatening clinical entity. Am J Med Sci. 2009 Sep; 338(3):217-24. view on PubMed
Kelesidis T, Tozzi S, Mitty R, Worthington M, Fleisher J. Cytomegalovirus pseudotumor of the duodenum in a patient with AIDS: an unrecognized and potentially treatable clinical entity. Int J Infect Dis. 2010 Apr; 14(4):e274-82. view on PubMed
Kelesidis T, Canseco E. Levofloxacin-induced hypoglycemia: a rare but life-threatening side effect of a widely used antibiotic. Am J Med. 2009 Mar; 122(3):e3-4. view on PubMed
Mantzoros CS, Rifas-Shiman SL, Williams CJ, Fargnoli JL, Kelesidis T, Gillman MW. Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study. Pediatrics. 2009 Feb; 123(2):682-9. view on PubMed
Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother. 2008 Nov; 62(5):895-904. view on PubMed
Kugeler KJ, Mead PS, McGowan KL, Burnham JM, Hogarty MD, Ruchelli E, Pollard K, Husband B, Conley C, Rivera T, Kelesidis T, Lee WM, Mabey W, Winchell JM, Stang HL, Staples JE, Chalcraft LJ, Petersen JM. Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood. J Clin Microbiol. 2008 Jul; 46(7):2428-31. view on PubMed
Kelesidis T, Balba G, Worthington M. Axillary abscess in a patient with Yersinia enterocolitica infection as a result of exposure to pork. Am J Med. 2008 Mar; 121(3):e1. view on PubMed
Tsiodras S, Kelesidis T, Kelesidis I, Bauchinger U, Falagas ME. Human infections associated with wild birds. J Infect. 2008 Feb; 56(2):83-98. view on PubMed
Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007 Dec; 26(12):857-68. view on PubMed
Blüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care. 2007 Feb; 30(2):280-5. view on PubMed
Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab. 2007 Apr; 92(4):1510-6. view on PubMed
Körner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007 Mar; 92(3):1041-8. view on PubMed
Bullen JW, Bluher S, Kelesidis T, Mantzoros CS. Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab. 2007 Apr; 292(4):E1079-86. view on PubMed
Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006 May 08; 94(9):1221-5. view on PubMed
Tsiodras S, Kelesidis T, Kelesidis I, Voumbourakis K, Giamarellou H. Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Eur J Neurol. 2006 Feb; 13(2):112-24. view on PubMed
Chan JL, Stoyneva V, Kelesidis T, Raciti P, Mantzoros CS. Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin. Diabetologia. 2006 Jan; 49(1):169-73. view on PubMed
Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect. 2005 Dec; 51(5):343-54. view on PubMed
